Works matching Antimetabolites


Results: 1264
    1
    2
    3
    4
    5
    6

    Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) Trial.

    Published in:
    Ocular Immunology & Inflammation, 2024, v. 32, n. 6, p. 955, doi. 10.1080/09273948.2023.2165949
    By:
    • Sura, Amol A.;
    • Sun, Yuwei;
    • Reddy, Amit K.;
    • Rathinam, S. R.;
    • Gonzales, John A.;
    • Thundikandy, Radhika;
    • Vedhanayaki, Rajesh;
    • Kanakath, Anuradha;
    • Murugan, Bala;
    • Doan, Thuy A.;
    • Lim, Lyndell L.;
    • Suhler, Eric B.;
    • Al-Dhibi, Hassan A.;
    • Acharya, Nisha R.
    Publication type:
    Article
    7

    Association between Quality of Life and Visual Acuity in a Randomized Clinical Trial of Patients with Uveitis Taking Antimetabolites.

    Published in:
    Ocular Immunology & Inflammation, 2024, v. 32, n. 3, p. 301, doi. 10.1080/09273948.2023.2169714
    By:
    • Chattopadhyay, Aheli;
    • Rathinam, SR;
    • Gonzales, John A.;
    • Kelly, Nicole K.;
    • Thundikandy, Radhika;
    • Kanakath, Anuradha;
    • Murugan, S. Bala;
    • Vedhanayaki, R.;
    • Lim, Lyndell L.;
    • Suhler, Eric B.;
    • Al-Dhibi, Hassan A.;
    • Doan, Thuy;
    • Ebert, Caleb D.;
    • Porco, Travis C.;
    • Acharya, Nisha R.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.

    Published in:
    Ocular Immunology & Inflammation, 2022, v. 30, n. 1, p. 198, doi. 10.1080/09273948.2020.1774906
    By:
    • Kong, Christina L.;
    • Kelly, Nicole K.;
    • Sundararajan, Miel;
    • Rathinam, S.R.;
    • Gonzales, John A.;
    • Thundikandy, Radhika;
    • Vedhanayaki, Rajesh;
    • Kanakath, Anuradha;
    • Murugan, Bala;
    • Doan, Thuy;
    • Goldstein, Debra;
    • Al-Dhibi, Hassan A.;
    • Acharya, Nisha R.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial.

    Published in:
    Journal of Ophthalmic Inflammation & Infection, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s12348-023-00350-5
    By:
    • Reddy, Amit K.;
    • Miller, D. Claire;
    • Sura, Amol A.;
    • Rathinam, SR;
    • Gonzales, John A;
    • Thundikandy, Radhika;
    • Kanakath, Anuradha;
    • Murugan, Bala;
    • Vedhanayaki, Rajesh;
    • Lim, Lyndell L.;
    • Suhler, Eric B.;
    • Doan, Thuy;
    • Al-Dhibi, Hassan A.;
    • Goldstein, Debra A.;
    • Arellanes-Garcia, Lourdes;
    • Acharya, Nisha R
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50